ÂÜÀòÂÒÂ×

Colin Smith is an accomplished finance executive with extensive experience in Chief Financial Officer roles across various companies. Currently serving as Group Chief Financial Officer at D3O since January 2016, Colin joined the Board following a 2015 Private Equity transaction. Prior to D3O, Colin held the position of Group Chief Financial Officer at hurleypalmerflatt from December 2011 to August 2019, where strategic restructuring and acquisition negotiations resulted in significant EBITDA growth. Colin's tenure at Stanmore Implants and Finsbury Orthopaedics involved raising equity capital and clarifying business strategies to enhance shareholder value. Earlier roles include Managing Director/Financial Director at Spaform, where restructuring efforts led to a successful sale, and Financial Director at Thomas Sanderson, contributing to a Private Equity-backed management buyout and subsequent sale.